Latest News

News shared by the University of Queensland (UQ) in December 2023 details explains how a paper in Molecular...

In 1988 the first World AIDs Day was launched under the theme “A world united against AIDS”; in...

In research shared by the University of Bristol in November 2023, a team demonstrate the validity of nature-inspired...

Last month we were delighted to speak to so many of our fantastic speakers and exhibitors and here...

In November 2023 Merck, which is known as MSD outside the US and Canada, announced results from a...

In November 2023 CEPI, IVI, and Gambia’s Medical Research Council Unit The Gambia (MRCG) announced the launch of...

In November 2023 the University of Saskatchewan’s Vaccine and Infectious Disease Organisation (VIDO) announced that it has been...

With the World Vaccine Congress West Coast kicking off today we are pleased to share another exclusive interview...

In November 2023 the UKHSA stated that a single human case of influenza A(H1N2)v has been detected in...

The University of Queensland (UQ) announced in November 2023 that its “re-engineered clamp platform” has produced a vaccine...

Our next interview in the European Congress series is with Africa CDC's Akhona Tshangela, who joined us at...

WHO shared a statement in November 2023 that reveals an “official request” to China for “detailed information” on...

A joint news release from WHO, UNICEF, and Gavi in November 2023 states that shipments of the first...

In November 2023 SK bioscience and Hilleman Laboratories shared that they have entered into a development licensing agreement...

Our next Congress Conversation from the event in Barcelona last month is with Andreas Regnery, who represented Belyntic...

In a paper for Vaccine in November 2023 an international group of authors comment on the “unjust” distribution...

With the Congress only days away we are delighted to share another exclusive Congress Conversation ahead of the...

In a feature for The BMJ in November 2023 Hristio Boytchev reports on concern raised by “some experts”...

In November 2023 Micron Biomedical announced that the Bill and Melinda Gates Foundation has committed a $23.6 million...

In a white paper shared in November, Vaccines Europe explores how vaccination can be a “valuable tool” to...

Next up in our exciting Congress Conversations series is an interview with Genoskin's Dr Nicolas Gaudenzio. He joined...

A team of researchers shared in November 2023 that their study, published in Nature Medicine, has provided insight...

As the threat presented by antimicrobial resistance (AMR) grows globally, the pressure is mounting on the vaccine community...

With the Congress behind us we are able to reflect on the key themes and discussions that took...

In November 2023 the UK’s Joint Committee on Vaccination and Immunisation (JCVI) announced that it was recommending a...

In November 2023 the UKHSA and University of Bristol shared a report that reveals the results of an...

In what WHO is describing as a “significant stride towards facilitating and informing priorities in global vaccine development”...

In November 2023 the UK’s Joint Committee on Vaccination and Immunisation issued advice to the government on a...

In November 2023 Valneva announced that the US FDA has approved its single-dose, live-attenuated vaccine for the prevention...

In a study published in BMC Medical Ethics the authors present a systematic review of normative arguments made...

Research published in Cell Host & Microbe in November 2023 reaches a “somewhat provocative conclusion” that HPV vaccination...

In November 2023 BioCina and GPN Vaccines announced that they are expanding their partnership to develop GPN’s proprietary...

In November 2023 the WHO shared the Global Tuberculosis Report 2023, a “comprehensive and up-to-date assessment” on the...

In October 2023 at the Global Gateway Forum, held in Brussels, the EU Commission signed €500 million for...

In October 2023 MSD Animal Health announced that the European Medicines Agency Committee for Veterinary Medicinal Products (CVMP)...

Researchers from the University of Maryland shared in November 2023 that they have made progress in developing a...

In November 2023 the UK’s Minister for Health and Secondary Care, Will Quince, announced at the Association of...

In November 2023 CEPI and the University of Oxford announced a new project to “initiate the early development...

Friday 3rd November 2023 is the 8th annual One Health Day, observed internationally to “raise global awareness” of...

Researchers from the University of Birmingham shared in October 2023 that a paper in Blood identifies how blood...

In October 2023 the European Vaccine Initiative (EVI) announced that it will be coordinating a new partnership to...

Research published in mBio in October 2023 shows that artificial intelligence (AI) could be used to effectively identify...

A report shared by the Global Preparedness Monitoring Board (GPMB) in 2023 offers a “warning” that the “fragile...

In October 2023 AXA published the 10th edition of its Future Risks Report, a study that “measures and...

In October 2023 CEPI and Moderna announced a strategic partnership to “harness Moderna’s mRNA platform” for vaccine development...

In October 2023 the Tripartite organisations, issued an update on oral vaccination of dogs against rabies: recommendations for...

Human Immune Project (HIP), a global nonprofit organisation dedicated to “decoding and modelling the immune system”, shared a...

200 health journals published an editorial demanding recognition that “climate change and biodiversity loss” are “one indivisible crisis”...

An artificial intelligence (AI) tool developed by a team from the University of Oxford and Harvard Medical School...

In October 2023 the University of Oxford’s Oxford Vaccine Group announced funding from the Medical Research Council within...

On 24th October 2023 global health leaders, advocates, and communities highlight efforts to end poliomyelitis (polio). Each year...

With our Congress in Barcelona mere days away we are glad to share another of our exclusive speaker...

In October 2023 the European Commission, the European Investment Bank, and the Bill & Melinda Gates Foundation announced...

The World Vaccine Congress in Barcelona is so close (less than a week now!) and we are delighted...

Our World Vaccine Congress in Barcelona is now next week and our start-up zone has reached capacity! This...

In October 2023 Franco-Canadian Angany announced that it has received a Notice of Acceptance from the UK’s Medicines...

In October 2023 the UK Research and Innovation (UKRI) announced £25 million funding to three projects “designed to...

With just a week to go until the Congress in Barcelona we are delighted that another of our...

The University of Aberdeen announced in October 2023 that a team of scientists has “taken an important step”...

At the 2023 Grand Challenges Annual Meeting in October 2023 Bill Gates announced new Bill and Melinda Gates...

In October 2023 GSK announced that it has secured an exclusive agreement with Chongqing Zhifei Biological Products (Zhifei)...

Research published in Science Translational Medicine and shared by the University of Southern California in October 2023 demonstrates...

A commentary in The Lancet in October 2023 calls for a “gender-responsive” Pandemic Accord to secure a “healthier...

With less than a fortnight to go until the Congress in Barcelona we are thrilled to share another...

In October 2023 Sanofi announced that it has joined forces with Janssen Pharmaceuticals to develop and commercialise the...

In a paper published in the Journal of Public Health in Africa in September 2023 a team of...

In October 2023 the WHO issued a statement with updates about the outbreak of Nipah virus that was...

We are now down to just weeks to the  World Vaccine Congress in Barcelona, and our start-up zone...

The “nexus of women, power, and cancer” is the subject of investigation by The Lancet Commission in September...

A paper in npj vaccines presents the results of a study assessing the efficacy of VLP-based vaccines displaying...

The UKHSA and Office of National Statistics (ONS) announced in October 2023 that they are launching a “vital...

In October 2023 the University of Oxford announced that the WHO has recommended its malaria vaccine for the...

On 2nd October 2023 the Nobel Prize in Physiology or Medicine 2023 was announced as jointly awarded to...

In September 2023 the WHO announced recommendations for the viral composition of influenza vaccines for the 2024 influenza...

In September 2023 the University of Birmingham shared that the Bacterial Vaccines Network (BactiVac) was awarded £1.4 million...

In September 2023 Gavi announced the publication of its 2022 Annual Progress Report, which presents insights into a...

CEPI announced a “renewed collaboration” with Global Affairs Canada, comprising CAD 1 million in funding to “accelerate the...

Before and during the COVID-19 pandemic that Africa’s demand for vaccines exceeds its local supply: 99% of vaccines...

Although insufficient attention has been directed towards the effects of vaccination on menstrual experiences, a study published in...

In September 2023 Gritstone bio announced that is has been awarded a contract by BARDA to conduct a...

In September 2023 Revital Healthcare announced a “historic milestone in African manufacturing excellence”. The company was awarded Pre-Qualification...

WHO shared Considerations for developing a national genomic surveillance strategy or action plan for pathogens with pandemic and...

In the last few weeks before the World Vaccine Congress in Barcelona, our start-up zone is reaching capacity! This...

The University of Cambridge announced in September 2023 that a vaccine antigen technology developed in collaboration with spin-out...

In September the UKHSA announced an agreed deal for “millions of life-saving vaccines” has been signed with CSL...

Pandemic Centre at Brown University School of Public Health publication emphasises the importance of “identification, attribution, and consequence...

At the United Nations General Assembly high-level meeting on tuberculosis world leaders approved a political declaration reaffirming their...

Data from the WHO published in September 2023 offer an insight into the extent of cholera surges across...

The UK’s International Development Minister Andrew Mitchell and Health Minister Will Quince announced investments in “ground-breaking research and...

In September 2023 Vir Biotechnology announced that the first participant in a Phase I trial has been dosed...

In September 2023 Google’s AI organisation, DeepMind, released a catalogue of genetic mutations intended to accelerate disease diagnosis...

At the UNGA 78th session in September 2023 a “landmark declaration” was adopted on pandemic prevention, preparedness, and...

In September 2023 CEPI and Bio Farmer announced the agreement of a 10-year partnership to “boost rapid manufacturing...

With less than a month until the World Vaccine Congress in Barcelona, our start-up zone is continuing to grow!...

A study carried out by Charles River Associates (CRA) for Vaccines Europe (VE) in June 2023 investigates the...

In September 2023 the University of Oxford’s Pandemic Sciences Institute (PSI) announced that a Phase I clinical trial...

In September 2023 BioNTech and CEPI announced a strategic partnership to advance mRNA-based vaccine candidates for the prevention...

An update from Wageningen Bioveterinary Research in September 2023 shared that the European reference laboratory in Madrid has...

India announces containment measures to control the spread of Nipah, detected in the southern state of Kerala, attention...

In September 2023 CEPI and the University of California, Davis (UC Davis) announced a partnership to advance human...

In September 2023 the UKHSA announced that the flagship SIREN study is “entering a new phase” of surveillance...

Next week, from 18th to 26th September 2023, the United Nations General Assembly (UNGA) will take place in...

In September 2023 the Oxford Vaccine Group (OVG) and Pandemic Sciences Institute (PSI) of the University of Oxford...

With just over a month until the World Vaccine Congress in Barcelona, our start-up zone is continuing to grow!...

In September 2023 Ose Immunotherapeutics announced the publication of new data supporting its cancer vaccine, Tedopi, in HLA-A2...

A paper published in Nature Communications in September 2023 presents the results of an investigation into the effects...

A vaccine developed by researchers at the University of Chicago’s PME has demonstrated in the lab that it...

As we find ourselves in September and ever closer to the Congress in Barcelona next month, our interview...

A team at the Massachusetts Institute of Technology (MIT) is working on COVID-19 RNA vaccine optimisation to try...

In September 2023 the Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Institute (IVI) announced a...

Researchers at Ohio State University offered an insight into their work against leishmaniasis in August 2023. Phase I...

Getting closer to the World Vaccine Congress in Barcelona this October, our start-up zone is continuing to grow! We are...

The UK government announced in August 2023 that the autumn flu and COVID-19 vaccine programmes will start “earlier...

A lot of attention has been directed towards vaccine stability as the COVID-19 pandemic highlighted the weaknesses of...

A partnership involving a team at the University of Montana, funded by NIH, suggests that it is “nearing...

In August 2023 CEPI announced a commitment of up to $80 million to support the design, manufacture, and...

Albert Einstein College of Medicine announced in August that their publication in Nature Microbiology could help vaccine development...

In August 2023 WHO announced that the COVID-19 Technology Access Pool (C-TAP) has announced three new licensing agreements...

A business agreement signed between GC Biopharma and EuBiologics in August 2023 allows the companies to jointly produce...

In August 2023 Vaxxas announced that Wellcome has awarded the company £2.84 million to conduct IND-enabling studies and...

In August 2023 researchers in an international partnership shared the results of a Phase III study in The...

In August 2023 as the new academic year looms, the UKHSA and leading meningitis charities are “urging” students...

The US Department of Health and Human Services (HHS) announced in August 2023 that it awarded more than...

In August 2023 KFF shared the results of its Health Misinformation Tracking Poll Pilot as part of a...

A collaboration between Chinese company CARsgen and Texas-based Moderna was announced by the former in August 2023. The...

With under two months until our World Vaccine Congress in Barcelona this October, our start-up zone is continuing...

In August 2023 Pfizer announced that the US FDA has approved its vaccine against RSV in infants through...

The UK Department of Health and Social Care announced that it was supporting “laboratories”, disease surveillance, and a...

Farmers Weekly reported on discussions to develop a pathway for approval of the export of cattle vaccinated with...

In this post we are thrilled to share a pre-event conversation with Solve M.E.'s President and CEO Oved...

In a statement released in August 2023 Moderna announced that preliminary clinical trial data “confirm” that the updated...

In August 2023 the announcement of the newly unveiled Vaccine Development and Evaluation Centre in the UK provoked...

We are inching ever closer to World Vaccine Congress in Barcelona this October, and our start-up zone is still growing!...

Moredun Research Institute announced that it is leading an international partnership with the University of Glasgow and the...

In August 2023 Gritstone bio and Genevant Sciences announced an agreement through which Gritstone will be able to...

The EG.5 variant of SARS-CoV-2, identified in February 2023, has been classed as a “variant of interest (VOI)...

A study in Vaccines against Influenza virus presents a systematic review and meta-analysis of RCTs and TNDs to...

In a study published in Nature Communications in August 2023 presents early findings for a “cutting-edge” vaccine candidate...

2nd August 2023, Dr Seth Berkley’s tenure as CEO of Gavi came to an end after 12 years...

In August 2023 the UKHSA shared an announcement from the Joint Committee on Vaccination and Immunisation (JCVI) regarding...

Another week closer to World Vaccine Congress in Barcelona this October, and our start-up zone is expanding all the time! This week...

In August 2023 CEPI and Gennova Biopharmaceuticals Ltd announced a funding agreement of up to $3.6 million to...

In August 2023 the UKHSA announced the opening of its “world-leading” Vaccine Development and Evaluation Centre in the...

Economist Impact’s The Vaccine Ecosystem launched the Immunisation Readiness Index, which measures the enabling environment for immunisation...

In August 2023 the Access to Advanced Health Institute (AAHI) announced that it had received an $18 million...

With just over two months left until the World Vaccine Congress in Barcelona this October our start-up zone...

Just weeks into her new role as Director of the US CDC, Dr Mandy Cohen has been busy...

In a report published by the European Medicines Agency in July 2023 the lessons from the COVID-19 and...

In July 2023 The Indian Express reported that the Pune-based ICMR-NIV nationwide survey had found evidence of Nipah...

IO Biotech announced that the University of California Davis Comprehensive Cancer Centre has dosed the first patient in...

An article in Vaccine: X in August 2023 acknowledges that previous research has identified religion as one of...

A team from Japan’s Juntendo University suggest that their latest vaccine, “SAGP”, may revolutionise treatment of Alzheimer’s disease...

In July 2023, just days after we reported on a concerning lack of EAE vaccines in the UK...

Under the call to action “We’re not waiting”, World Hepatitis Day takes place on 28th July 2023. This...

In research published in Brain, Behaviour, and Immunity in July 2023, a group from Tel Aviv University found...

MPs in the UK have warned that the country risks losing its place as a global leader in...

In July 2023 Farmers Guide reported that delays in the supply of a vaccine for EAE (enzootic abortion...

Merck and Moderna announced the initiation of a Phase III clinical trial evaluating V940 (mRNA-4157) in combination with...

As we get closer to the World Vaccine Congress in Barcelona this October our start-up zone is growing...

WHO reported in July 2023 that the National Centre for Epidemiology, Prevention, and Disease Control (CDC) of Peru...

In July 2023 the UK Health Security Agency (UKHSA) announced a new strategy, outlining its “vision and goals”...

A study in BMJ Global Health in July 2023 uses a static proportional impact model to explore the...

A report by IQVIA Institute for Human Data Science, in collaboration with GSK and the Global Coalition on...

A review in July 2023 describes adjuvants as “indispensable components of vaccines” that are widely used but not...

After a meeting of the Federal, Provincial, and Territorial (FPT) Ministers of Agriculture in Canada, Ministers confirmed their...

In July 2023 VitriVax announced that it had been awarded a $29 million contract over 5 years from...

Less than a month since we reported Vaxxinity’s “promising” results in a trial of UB-312, the company has...

Pfizer announced data from a Phase II study investigating its hexavalent capsular polysaccharide (CPS) conjugate Group B Streptococcus...

During the Congress last month we were pleased to meet Dr Pravin Kaumaya for a conversation about the...

Africa CDC, WHO, and the Robert Koch Institute (RKI) launched a Health Security Partnership intended to strengthen disease...

Blue Water Biotech announced preliminary preclinical data in support of the use of a norovirus shell and protrusion...

In a partnership announced in July 2023, CEPI and the Houston Methodist Research Institute (HMRI) will combine cutting-edge...

In July 2023 UNAIDS released a report outlining a “clear path” to end AIDS and prepare for and...

Data from WHO and UNICEF, shared in July 2023, suggest that fewer children missed routine vaccinations in 2022...

Although dengue, a viral infection transmitted through mosquito bites, threatens the health of “about half of the world’s...

Data from the UKHSA in July 2023 suggests a “steady rise” in measles cases in the UK throughout...

A letter from the US Secretary of Health and Human Services (HHS) in July 2023 to COVID-19 vaccine...

Africa CDC, the “autonomous public health institution of the African Union” (AU) announced in July 2023 that a...

Serum Institute of India (SIIPL) and PATH announced that the first conjugate vaccine against the five predominant causes...

As we gear up for October’s World Vaccine Congress in Europe, we are delighted to see our start-up zone...

WHO, Food and Agriculture Organisation (FAO), and the World Organisation for Animal Health (WOAH) united in a statement...

In July 2023 it was announced that preliminary analysis of vaccine trial results demonstrates the induction of “high...

In a paper in Nature reviews immunology in July 2023 a group of scientists investigate the “immunology” long...

In an article for the World Economic Forum in July 2023 the importance of investment in childhood vaccines...

The World Organisation for Animal Health reminds us that rabies continues to kill around 59,000 people a year...

In a study published in Frontiers in Psychology researchers examine the link between conspiracy mindsets and uptake of...

WHO reported in July 2023 that Member States within the European Region had notified the organisation of cases...

In July 2023 the International Federation of Gynaecology and Obstetrics (FIGO) published a supplement in the International Journal...

In July 2023 it was announced that Sanofi had signed a Memorandum of Understanding (MoU) with Lifer and...

In July 2023 it was announced that Moderna had established an agreement with China to develop mRNA products...

Following the signing of a memorandum between the UK government and BioNTech in January 2023, an agreement has...

In a collaboration 12 countries across different regions in Africa are expected to receive a total of 18...

In a Defra-commissioned study published in VetRecord researchers investigated the attitudes of farmers to different vaccination approaches to...

In an update from the UK government in July 2023 over 3 million secondary school pupils will be...

A paper in BMC Medicine presents an apparent solution to the economic obstacles to the development and use...

At the end of June 2023 reports circulated that the EU Commission was preparing deals in anticipation of...

As animal influenza continues to cause concern across the world, OFFLU has shared a 2022 report to showcase...

In June 2023 Wellcome and the Bill and Melinda Gates Foundation announced funding to advance a tuberculosis (TB)...

As we gear up for October’s World Vaccine Congress in Europe, we are delighted to see our start-up...

In a Nature Communications article in June 2023 a group of European-based researchers present results of screening for...

The contentious introduction of a vaccine mandate for staff in elderly care homes in England in 2021 was...

An article in Nature Communications in June 2023 presents research into age-associated B cells (ABCs) and how they...

A narrative review of vaccine hesitancy in pregnant women concludes that “hesitancy is dynamic”, and people “do not...

CEPI announced a new partnership agreement to “advance and accelerate” RVAC’s manufacturing process for next-generation mRNA vaccine platform...

In June 2023 Vaxxinity announced positive results from Part B of the Phase I clinical trial of UB-312...

The WHO reported that a project from 2022 helped health systems become more resilient, arming them against epidemics...

In June 2023 GSK announced that the US FDA has granted fast track designation for its Neisseria gonorrhoeae...

CEPI issued a Call for Proposals for research teams interested in collaborating on a consortium to create a...

In an article in June 2023 Dr Andreas Papamichail explores the importance of health policy in addressing “deep-rooted...

A review suggests that for Africa, a “high prevalence of infectious diseases" is combining with “weak healthcare systems...

In June 2023 Gavi, the Vaccine Alliance, announced that it has contributed to efforts to vaccinate over 1...

A study in Human Vaccines and Immunotherapies in June 2023 found that confidence in vaccines declined across much...

In June 2023 CEPI and Celestial Therapeutics announced a partnership to advance the development of Celestial’s “self-adjuvanting mRNA”...

Researchers at 19 institutions comprising the TBVAC-HORIZON have been awarded €9 million in funding to encourage research and...

In June 2023 Valneva announced the publication of Phase III data for its single-shot chikungunya vaccine candidate VLA1553...

In June 2023 at the European Haematology Association Mendus presented new clinical data from the Phase II ADVANCE...

In June 2023 the WHO called for “focused efforts” from countries in the South-East Asia region to provide...

In June 2023 the Deputy Prime Minister of the UK, Oliver Dowden, announced that a new Biothreats Radar...

In June 2023 the WHO and the Global Fund to Fight AIDS, Tuberculosis, and Malaria (the Global Fund)...

Researchers in Nebraska believe they are getting closer to an effective and potentially universal vaccine for swine flu...

During the COVID-19 pandemic the rate of technology acceleration was remarkable, and many communities across the globe were...

In June 2023 CEPI and the Institute for Drug Discovery at Leipzig University announced a partnership to speed...

A grant of €7.6 million from the EU will contribute to the efforts of a consortium of academic...

Our next interview from the Congress last month was a recorded conversation with BARDA's Dr Sandeep Patel. Dr...

CEPI and aVaxziPen Ltd announced in June 2023 that they are partnering to advance the development of two...

In June 2023 Moderna and Merck, who have been collaborating on a Phase IIb study to evaluate mRNA-4157...

Novavax announced in June 2023 that it has signed a three-year agreement with the Bill and Melinda Gates...

In June 2023 VaxEquity and CPI announced a grant of around £700k from Innovate UK, which will fund...

French-based biotechnology company Transgene announced in June 2023 that new data confirm that its novel investigational therapeutic cancer...

Next in our series of conversations with experts at the Congress last month is founding CEO of Valneva...

Global disruptions to routine vaccination occurred during the COVID-19 pandemic setting vaccination programs back decades, risking future disease...

At the Congress in Washington last month we were lucky to meet Conservation X Labs CEO and co-founder...

Our next conversation from the Congress last month is an interview with PharmaJet's Dr Carmen Ledesma-Feliciano. Dr Ledesma-Feliciano...

Next in our interview series is CEPI's Dr Matthew Downham, who joined us at the Congress for a...

Our next interviewee is Dr Ofer Levy of Boston Children's Hospital; he joined us in Washington for several...

As part of our series of conversations with experts at the Congress in Washington last month we were...

Our next interview guest from the Congress last month is Genvax Technologies' CEO and Co-Founder, Joel Harris. Joel...

During the Congress last month we were lucky that Dr Jules Millogo made time to meet for a...

Next up in our exclusive series of Congress interviews is this conversation with David Humphreys, Global Head of...

Our next guest is Dr Andrew Catchpole, hVIVO's Chief Scientific Officer, who joined us in Washington for the...

The clinical trial of an experimental universal influenza vaccine developed by researchers from the Vaccine Research Centre has...

Last month, I had the pleasure of attending the World Vaccine Congress—an experience that left me feeling inspired...

Next up in our series of Congress interviews is our conversation with Professor Petro Terblanche, CEO of Afrigen...

Our next interview is with Dr Jay Berzofsky, Chief of the Vaccine Branch at NCI's Centre for Cancer...

At the World Vaccine Congress last month we were lucky to meet Dr Nora Disis of the University...

Just days after the COVID-19 pandemic was declared no longer a public health emergency of international concern (PHEIC)...

An article in Nature in May 2023 presents work from a collaboration between Genentech, Memorial Sloan Kettering Cancer...

In this interview we meet Mei Mei Hu, CEO and Co-Founder of Vaxxinity. She joined us at the...

At last month's Congress we were lucky to meet Dr Andrew Allen, CEO and Co-Founder of Gritstone Bio...

Captain Dr Jennifer McQuiston joined us at the Congress last month to discuss the importance of animal vaccines...

After the "termination and suspension” of a grant awarded in 2019, NIH and EcoHealth Alliance have announced a...

In 2018 Integrum Scientific was formed by a "group of global innovators" in response to "the need to...

A study in Pediatrics in May 2023 explores the effects of different messaging angles on parents’ intentions to...

Committee members advised the WHO Director General that the pandemic is no longer a public health emergency of...

In an article published in NEJM in May 2023 experts from the Division of Vector-Borne Diseases “revisit the...

The UK Health Security Agency (UKHSA) published data in May 2023 that reveal a rise in measles cases...

In May 2023 the US FDA announced approval of Arexvy, the first respiratory syncytial virus vaccine to be...

Our next interview in the exclusive Congress series is our conversation with Gabriella Hakim of VacTrack. Gabriella is...

Research shared in Nature in May 2023 details work by a team from Baidu to develop an AI...

As part of our exclusive interviews conducted at the World Vaccine Congress this month we are delighted to...

Shortly after the publication of UNICEF’s State of the World’s Children report in April 2023, UNICEF explored the...

As became apparent during the COVID-19 pandemic, long-existing health inequalities mean that a location’s experience of public health...

The University of Liverpool announced in April 2023 that the first participant has received a dose of a...

Gavi announced in April 2023 that it is beginning a “push” to reach zero-dose children through a Zero-Dose...

Continuing our series of exclusive Congress interviews we are delighted to share a conversation with Dr Gaurav Gaiha...

On 25th April 2023 the WHO observed World Malaria Day with a call for “increased implementation” of “new...

In April 2023 Ultimovacs ASA announced that it has adjusted guidance for communication of top-line data from early 2023...

An article in Nature Biotechnology explores the possibility presented through an automated process for printing microneedle patch (MNP)...

A team at the University of Cambridge and spin-out DIOSynVax has developed a vaccine to protect against SARS-CoV-2...

As World Immunisation week (24-30 April) begins, we are exploring some of the WHO’s goals for the coming...

UKHSA issued a press release and blog, coinciding with the start of World Immunisation Week, which suggested that...

After an update from WHO in March 2023 on the Marburg virus situation in Equatorial Guinea and Tanzania...

A study published in Nature communications biology identifies “several factors associated with COVID-19 vaccine-induced adaptive immune responses”...

In April 2023 UNICEF published its The State of the World’s Children report with a focus on the...

In April 2023 the participants of the mRNA Technology Transfer Programme met for their first face-to-face meeting in...

Allergy Therapeutics announced that patients with peanut allergies had “successfully” taken the “innovative short-course peanut allergy vaccine candidate”...

In April 2023 PharmaJet announced that it had received a “scope expansion” and “3-year extension” of a multi-year...

WHO announced in 2023 that it was launching a new initiative to equip countries with the “systems and...

MinervaX announced in April 2023 that it is beginning a Phase I clinical study of its novel Group...

A study in PLOS Global Public Health in April 2023 presents a validation of the Vaccination Trust Indicator...

In a paper published in The Lancet Infectious Diseases, researchers detailed the results of a trial for a...

The Engineering and Physical Sciences Research Council (EPSRC) announced a £12 million investment to fund the Future Vaccines...

In April 2023 it was reported that Ghana is the first country to approve a new malaria vaccine...

UKHSA issued a press release explaining the risk assessment produced by HAIRS on the risk presented to the...

In an interview between Africa CDC and the Minister for Health in the Republic of Uganda, Dr Aceng...

Moderna announced in April 2023 that the mRNA-4157/V940 has been awarded Priority Medicines (PRIME) scheme designation by the...

After WHO revised vaccine guidance following a SAGE meeting, GlobalData issued a statement warning about the effects on...

As the countdown to the World Vaccine Congress in Washington continues with only days to go, we are...

After experts called for “transformational change” to the “epidemic countermeasures ecosystem”, our interest has been drawn to The Vaccine...

After a meeting in March 2023, WHO’s Strategic Advisory Group of Experts on Immunisation (SAGE) revised the roadmap...

A study published in Nature Medicine in March explores the factors associated with so-called “vaccine fatigue”, with a...

In March 2023 the heads of the Quadripartite organisations working on One Health issued a call for greater...

In March 2023 the CDC commented on data that revealed an “alarming” spread of the emerging fungus Candida...

A study released in iScience suggests that COVID-19 infection was a greater factor than COVID-19 vaccination in observed changes...

After we reported in March 2023 that possibly critical data concerning the Huanan Seafood Wholesale Market had been...

Just under a month after the confirmation of an outbreak of Marburg virus disease (MVD) in Equatorial Guinea...

A study in Microbiology Spectrum in March 2023 demonstrated the benefits of an oral vaccine for COVID-19 that...

On Friday 24th March 2023 the WHO and other organisations and individuals observe ‘World Tuberculosis Day’ with the...

In a study published in Nature Communications, researchers investigate the socioeconomic benefits of a set of “idealised” vaccine...

In March 2023 the board of directors at CSPC Pharmaceutical Group Limited announced that the company’s COVID-19 mRNA...

Africa CDC has confirmed that the Ministry of Health of the Republic of Tanzania declared an outbreak of...

Vaxxinity announced that the first subjects of a Phase I trial had been dosed. The trial of VXX-401...

In March 2023, Vaccitech announced top-line interim data from a Phase Ib/II clinical trial of its VTP-200 vaccine...

SpyBiotech, a biotechnology company spin out from the University of Oxford, announced in March 2023 that it had...

With just weeks to go until the World Vaccine Congress in Washington, we are delighted to share our...

In March 2023, RVAC Medicines and the University of Pennsylvania (Penn) announced a collaboration to pursue the development...

In March 2023 new metagenomics data and SARS-CoV-2 sequences appeared on GISAID and were available to researchers across...

The Global Polio Eradication Initiative (GPEI) and WHO Africa confirmed that cases of circulating vaccine-derived poliovirus type 2...

A study published in PLOS Medicine in March 2023 suggests that the human and financial benefits of a...

In March 2023 WHO Africa reported that the Ugandan Ministry of Health is planning to vaccinate over 1.9...

South Korean chemical company LG Chem announced in March 2023 that it will supply essential vaccines for infants...

In March 2023 GSK announced positive headline results from a Phase III trial evaluating its MenABCWY combination vaccine...

Writing in The Lancet in March 2023, public health experts called for “ambitious, transformational change” to the “epidemic...

With just weeks to go until the World Vaccine Congress in Washington this April, we are delighted to...

Tuberculosis is one of the leading infectious causes of morbidity and mortality across the world. In 2020 it...

A study published in Current Biology suggests that getting sufficient sleep in the days surrounding vaccination is key...

We are pleased to share the organisations and individuals who have progressed to the final shortlist for the...

Researchers at Tel Aviv University and the Israel Institute for Biological Research announced that they have developed an...

Carrie Arnold explores cell-free processes and a “growing number of biomanufacturing firms” that are “embracing” a cell-free biosynthesis...

Researchers in France published a paper in Nature Communications in March detailing the results of an investigation into...

As we continue our countdown to the World Vaccine Congress in Washington we are delighted to share conversations...

Just after Pfizer announced that the Vaccines and Related Biological Products Advisory Committee had voted on its RSV...

In 2023, a few days after the FDA requested further studies into the link between GBS and its...

With just two months until the World Vaccine Congress we are delighted that some of our wonderful speakers...

After the news of the death of a child from avian influenza A (H5N1) in Cambodia in February...

Just months after the conclusion of an outbreak of Marburg, the Ghana Health Service has issued a statement...

Following the announcement of an outbreak of Marburg virus in Equatorial Guinea in February 2023, WHO has issued a...

Following the FDA’s acceptance for review for Pfizer’s respiratory syncytial virus (RSV) vaccine candidate, the agency has asked...

Researchers at the University of Queensland are pursuing an experimental vaccine to tackle a venereal disease that “causes...

A study in Midwifery in February 2023 examines the quality of maternal vaccination information available in pregnancy to...

With growing concern at the increasing cases of avian influenza in mammals across the world, the spread has...

After an update from WHO in November 2022 that almost 40 million children are “dangerously susceptible” to measles...